Ranbaxy standalone JQ Net dips 716%: For the period while the Net Sales increased by 19.02%, Net Profit dipped by 715.57% and thereby NPM reduced to 60.66% as compared to 11.73% on y-o-y basis.

1. Ranbaxy standalone JQ Net dips 716%
Ranbaxy Laboratories Limited
22-Aug-2012 | Quarterly Result as on 30-Jun-2012
For the period the Ranbaxy Laboratories Limited reported Net Sales of Rs 15258.98 million and Net Loss of Rs 9256.66 million. While Net
Sales rose by 19.02%, Net Profit came down by 715.57% and thereby NPM reduced to -60.66% as compared to 11.73% during same period
previous FY Equity Capital for the period under consideration has increased by 0.18% and stands at Rs 2110.56 million. EPS as on 30-Jun-
.
2012 stands at Rs -21.95 viz-a-viz Rs 3.57 as on 30-Jun-2011.
The stock of the Ranbaxy Laboratories Limited at BSE opened at 517.00 touched a high 537.75 and low 510.30 before closing at 534.50
gaining 4.12% over previous close. The trading volume for the stock at BSE stood at 313529 shares and at NSE stood at 1911968 shares.
BSE NSE
The BSE Sensex closed today at 17846.86 (0.21% loss) and Nifty closed at 5412.85 (0.15% loss).
Company Announcements
22-Aug-2012 11:51 AM Clarification
View Detailed Result
Follow us on This content is generated at www.finalaya.com and is governed by the Terms of Use.